Inari Medical Inc. (NASDAQ: NARI) is 10.94% higher on its value in year-to-date trading and has touched a low of $39.55 and a high of $54.86 in the current 52-week trading range. The NARI stock was last observed hovering at around $46.99 in the last trading session, with the day’s gains setting it 0.17% off its average median price target of $54.00 for the next 12 months. It is also 21.4% off the consensus price target high of $60.00 offered by 4 analysts, but current levels are 3.76% higher than the price target low of $49.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $47.16, the stock is -3.00% and -1.21% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.21 million and changing 0.36% at the moment leaves the stock -1.21% off its SMA200. The firm has a 50-day simple moving average (SMA 50) of $47.71 and a 200-day simple moving average (SMA200) of $47.71.
The stock witnessed a 10.32% gain in the last 1 month and is -2.10% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.43% over the week and 7.40% over the month.
Inari Medical Inc. (NARI) has around 240 employees, a market worth around $2.29B and $71.10M in sales. Current P/E ratio is 561.43. Profit margin for the company is 5.40%. Distance from 52-week low is 19.24% and -14.04% from its 52-week high. The company has generated returns on investments over the last 12 months (-3.00%).
Inari Medical Inc. (NARI) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Inari Medical Inc. (NARI) is a “Hold”. 4 analysts offering their recommendations for the stock have an average rating of 3.00, where 3 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Inari Medical Inc. is expected to release its quarterly report on 09/02/2020 and quarterly earnings per share for the current quarter are estimated at -$0.18 with sales reaching $13.15M over the same period.The EPS is expected to grow by 88.30% this year.
Inari Medical Inc. (NARI) Top Institutional Holders
The shares outstanding are 48.51M, and float is at 30.55M with Short Float at 0.06%.
Inari Medical Inc. (NARI) Insider Activity
A total of 27 insider transactions have happened at Inari Medical Inc. (NARI) in the last six months, with sales accounting for 0 and purchases happening 27 times.